A citation-based method for searching scientific literature

Carol Aghajanian, Stephanie V Blank, Barbara A Goff, Patricia L Judson, Michael G Teneriello, Amreen Husain, Mika A Sovak, Jing Yi, Lawrence R Nycum. J Clin Oncol 2012
Times Cited: 781



Bruce J Giantonio, Paul J Catalano, Neal J Meropol, Peter J O'Dwyer, Edith P Mitchell, Steven R Alberts, Michael A Schwartz, Al B Benson. J Clin Oncol 2007
Times Cited: 1648




List of shared articles



Times cited

Bevacizumab-associated events in Japanese women with cervical cancer: a multi-institutional survey of Obstetrical Gynecological Society of Kinki district, Japan.
Seiji Mabuchi, Misa Yamamoto, Hiroko Murata, Takuya Yokoe, Junzo Hamanishi, Yoshito Terai, Hikaru Imatake, Yasushi Mabuchi, Taisuke Mori, Fuminori Kitada,[...]. Int J Clin Oncol 2021
1


Risk stratification model based on VEGF and International Prognostic Index accurately identifies low-risk diffuse large B-cell lymphoma patients in the rituximab era.
Wei Sang, Hang Zhou, Yuanyuan Qin, Ziyuan Shen, Dongmei Yan, Cai Sun, Xuguang Song, Yuhan Ma, Dongyun Tu, Zhenzhen Bian,[...]. Int J Hematol 2021
0

Current Development of Monoclonal Antibodies in Cancer Therapy.
Sagun Parakh, Dylan King, Hui K Gan, Andrew M Scott. Recent Results Cancer Res 2020
5

Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook.
Josep Garcia, Herbert I Hurwitz, Alan B Sandler, David Miles, Robert L Coleman, Regula Deurloo, Olivier L Chinot. Cancer Treat Rev 2020
113